{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T22:45:38Z","timestamp":1785537938647,"version":"3.56.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T00:00:00Z","timestamp":1626134400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hepatitis C virus (HCV) causes life-threatening chronic infections. Implementation of novel, economical or widely available screening tools can help detect unidentified cases and facilitate their linkage to care. We investigated the relationship between chronic HCV infection and a potential complete blood count biomarker (the monocyte-to-platelet ratio) in the United States.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The analytic dataset was selected from cycle years 2009\u20132016 of the National Health and Nutrition Examination Survey. Complete case data- with no missingness- was available for <jats:italic>n<\/jats:italic>\u00a0=\u20095281 observations, one-hundred and twenty-two (<jats:italic>n<\/jats:italic>\u00a0=\u2009122) of which were exposed to chronic HCV. The primary analysis used survey-weighted logistic regression to model the effect of chronic HCV on the monocyte-to-platelet ratio adjusting for demographic and biological confounders in a causal inference framework. Missing data and propensity score methods were respectively performed as a secondary and sensitivity analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In the analytic dataset, outcome data was available for <jats:italic>n<\/jats:italic>\u00a0=\u20095281 (<jats:italic>n<\/jats:italic>\u00a0=\u200964,245,530 in the weighted sample) observations of which <jats:italic>n<\/jats:italic>\u00a0=\u2009122 (<jats:italic>n<\/jats:italic>\u00a0=\u20091,067,882 in the weighted sample) tested nucleic acid positive for HCV. Those exposed to chronic HCV infection in the United States have 3.10 times the odds of a high monocyte-to-platelet ratio than those not exposed (OR\u2009=\u20093.10, [95% CI: 1.55\u20136.18]).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>A relationship exists between chronic HCV infection and the monocyte-to-platelet ratio in the general population of the United States. Reversing the direction of this association to predict chronic HCV infection from complete blood counts, could provide an economically feasible and universal screening tool, which would help link patients with care.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-021-11267-w","type":"journal-article","created":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T12:06:04Z","timestamp":1626177964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Influence of chronic hepatitis C infection on the monocyte-to-platelet ratio: data analysis from the National Health and Nutrition Examination Survey (2009\u20132016)"],"prefix":"10.1186","volume":"21","author":[{"given":"Aidan M.","family":"Nikiforuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Ehsanul","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Patrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agatha N.","family":"Jassem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,13]]},"reference":[{"key":"11267_CR1","unstructured":"World Health Organisation. Global hepatitis report, 2017. Geneva; 2017. https:\/\/www.who.int\/hepatitis\/publications\/global-hepatitis-report2017\/en\/."},{"key":"11267_CR2","volume-title":"Hepatitis C. Fact Sheet","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. Hepatitis C. Fact Sheet. 2019. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c. Accessed 8 Jul 2019."},{"key":"11267_CR3","volume-title":"Blueprint to Inform Hepatitis C Elimination Efforts in Canada","author":"Canadian Network on Hepatitis C","year":"2019","unstructured":"Canadian Network on Hepatitis C. Blueprint to Inform Hepatitis C Elimination Efforts in Canada. 2019. https:\/\/pacificaidsnetwork.org\/files\/2019\/06\/blueprint_hcv_2019_05.pdf."},{"issue":"5","key":"11267_CR4","doi-asserted-by":"publisher","first-page":"293","DOI":"10.7326\/M13-1133","volume":"160","author":"MM Denniston","year":"2014","unstructured":"Denniston MM, Jiles RB, Drobeniuc J, Klevens RM, Ward JW, McQuillan GM, et al. Chronic hepatitis C virus infection in the United States, National Health and nutrition examination survey 2003 to 2010. Ann Intern Med. 2014;160(5):293\u2013300. https:\/\/doi.org\/10.7326\/M13-1133.","journal-title":"Ann Intern Med"},{"issue":"2","key":"11267_CR5","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.cgh.2019.04.035","volume":"18","author":"S Seo","year":"2019","unstructured":"Seo S, Silverberg MJ, Hurley LB, Ready J, Saxena V, Witt D, et al. Prevalence of spontaneous clearance of hepatitis C virus infection doubled from 1998 to 2017. Clin Gastroenterol Hepatol. 2019;18(2):511\u20133. https:\/\/doi.org\/10.1016\/j.cgh.2019.04.035.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"7","key":"11267_CR6","doi-asserted-by":"publisher","first-page":"584","DOI":"10.2174\/1389557517666170913111930","volume":"18","author":"D Das","year":"2018","unstructured":"Das D, Pandya M. Recent advancement of direct-acting antiviral agents (DAAs) in hepatitis C therapy. Mini-Reviews Med Chem. 2018;18(7):584\u201396. https:\/\/doi.org\/10.2174\/1389557517666170913111930.","journal-title":"Mini-Reviews Med Chem"},{"issue":"5","key":"11267_CR7","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1080\/14787210.2019.1604221","volume":"17","author":"S Chevaliez","year":"2019","unstructured":"Chevaliez S. Strategies for the improvement of HCV testing and diagnosis. Expert Rev Anti-Infect Ther. 2019;17(5):341\u20137. https:\/\/doi.org\/10.1080\/14787210.2019.1604221.","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"11267_CR8","doi-asserted-by":"publisher","first-page":"9.23.1","DOI":"10.1002\/cpph.19","volume-title":"Current protocols in pharmacology","author":"JK Aronson","year":"2017","unstructured":"Aronson JK, Ferner RE. Biomarkers-A General Review. In: Current protocols in pharmacology. Hoboken: John Wiley & Sons, Inc.; 2017. p. 9.23.1\u20139.23.17. doi:https:\/\/doi.org\/10.1002\/cpph.19."},{"issue":"4","key":"11267_CR9","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/S1665-2681(19)31836-8","volume":"7","author":"A Loaeza-del-Castillo","year":"2008","unstructured":"Loaeza-del-Castillo A, Paz-Pineda F, Oviedo-C\u00e1rdenas E, S\u00e1nchez-\u00c1vila F, Vargas-Vor\u00e1ckov\u00e1 F. AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis. Ann Hepatol. 2008;7(4):350\u20137. https:\/\/doi.org\/10.1016\/S1665-2681(19)31836-8.","journal-title":"Ann Hepatol"},{"key":"11267_CR10","volume-title":"National Health and Nutrition Examination Survey","author":"National Center for Health Statistics","year":"2019","unstructured":"National Center for Health Statistics. National Health and Nutrition Examination Survey. 2019. https:\/\/www.cdc.gov\/nchs\/nhanes\/index.htm."},{"issue":"1","key":"11267_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1756-0500-5-142","volume":"5","author":"TL Kauf","year":"2012","unstructured":"Kauf TL, Nelson DR, Schelfhout J, Delaney JA, Wang PF. Trends in the prevalence of thrombocytopenia among individuals iInfected with hepatitis C virus in the United States, 1999-2008. BMC Res Notes. 2012;5(1):142. https:\/\/doi.org\/10.1186\/1756-0500-5-142.","journal-title":"BMC Res Notes"},{"issue":"4","key":"11267_CR12","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1053\/jhep.2002.32486","volume":"35","author":"MB Streiff","year":"2002","unstructured":"Streiff MB, Mehta S, Thomas DL. Peripheral blood count abnormalities among patients with hepatitis C in the United States. Hepatology. 2002;35(4):947\u201352. https:\/\/doi.org\/10.1053\/jhep.2002.32486.","journal-title":"Hepatology."},{"issue":"44","key":"11267_CR13","doi-asserted-by":"publisher","first-page":"4962","DOI":"10.3748\/wjg.v24.i44.4962","volume":"24","author":"Y Yang","year":"2018","unstructured":"Yang Y, Tu Z-K, Liu X-K, Zhang P. Mononuclear phagocyte system in hepatitis C virus infection. World J Gastroenterol. 2018;24(44):4962\u201373. https:\/\/doi.org\/10.3748\/wjg.v24.i44.4962.","journal-title":"World J Gastroenterol"},{"key":"11267_CR14","doi-asserted-by":"publisher","first-page":"429290","DOI":"10.1155\/2015\/429290","volume":"2015","author":"M-H Tsai","year":"2015","unstructured":"Tsai M-H, Lin K-H, Lin K-T, Hung C-M, Cheng H-S, Tyan Y-C, et al. Predictors for early identification of hepatitis C virus infection. Biomed Res Int. 2015;2015:429290\u20137. https:\/\/doi.org\/10.1155\/2015\/429290.","journal-title":"Biomed Res Int"},{"key":"11267_CR15","volume-title":"National Health and Nutrition Examination Survey","author":"National Center for Health Statistics","year":"2019","unstructured":"National Center for Health Statistics. National Health and Nutrition Examination Survey: CDC\/National Center for Health Statistics; 2019. https:\/\/www.cdc.gov\/nchs\/nhanes\/index.htm. Accessed 1 Jan 2019."},{"key":"11267_CR16","volume-title":"The SAGE handbook of regression analysis and causal inference","author":"C Wolf","year":"2014","unstructured":"Wolf C, Best H. The SAGE handbook of regression analysis and causal inference. Los Angeles: SAGE Publications Ltd; 2014. https:\/\/uk.sagepub.com\/en-gb\/eur\/the-sage-handbook-of-regression-analysis-and-causal-inference\/book238839."},{"key":"11267_CR17","doi-asserted-by":"publisher","unstructured":"Heeringa SG, West BT, Berglund PA. Regression with Complex Samples. In: The SAGE Handbook of Regression Analysis and Causal Inference. London: SAGE Publications Ltd. p. 225\u201348. https:\/\/doi.org\/10.4135\/9781446288146.n11.","DOI":"10.4135\/9781446288146.n11"},{"key":"11267_CR18","volume-title":"Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans \u2013 TCPS 2. Policy","author":"Government of Canada Panel on Research Ethics","year":"2018","unstructured":"Government of Canada Panel on Research Ethics. Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans \u2013 TCPS 2. Policy. 2018. http:\/\/www.pre.ethics.gc.ca\/eng\/tcps2-eptc2_2018_chapter2-chapitre2.html."},{"key":"11267_CR19","volume-title":"Research Involving Human Participants. Policy","author":"The University of British Columbia Board of Governors","year":"2019","unstructured":"The University of British Columbia Board of Governors. Research Involving Human Participants. Policy. 2019. https:\/\/universitycounsel-2015.sites.olt.ubc.ca\/files\/2019\/08\/Human-Research-Policy_LR9.pdf."},{"key":"11267_CR20","volume-title":"National Health and nutrition examination survey: estimation procedures, 2007\u20132010","author":"L Mirel","year":"2013","unstructured":"Mirel L, Mohadjer L, Dohrmann S. National Health and nutrition examination survey: estimation procedures, 2007\u20132010. 2013. https:\/\/www.cdc.gov\/nchs\/data\/series\/sr_02\/sr02_159.pdf."},{"issue":"2","key":"11267_CR21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/hep.510260233","volume":"26","author":"F Roudot-Thoraval","year":"1997","unstructured":"Roudot-Thoraval F, Bastie A, Pawlotsky J, Dhumeaux D. Epidemiological factors affecting the severity of hepatitis C virus-related liver disease: a French survey of 6,664 patients. Hepatology. 1997;26(2):485\u201390. https:\/\/doi.org\/10.1002\/hep.510260233.","journal-title":"Hepatology."},{"issue":"9","key":"11267_CR22","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/S1473-3099(05)70216-4","volume":"5","author":"CW Shepard","year":"2005","unstructured":"Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;5(9):558\u201367. https:\/\/doi.org\/10.1016\/S1473-3099(05)70216-4.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"11267_CR23","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1162\/neco.2009.01-07-443","volume":"21","author":"ABA Graf","year":"2009","unstructured":"Graf ABA, Bousquet O, R\u00e4tsch G, Sch\u00f6lkopf B. Prototype classification: insights from machine learning. Neural Comput. 2009;21(1):272\u2013300. https:\/\/doi.org\/10.1162\/neco.2009.01-07-443.","journal-title":"Neural Comput"},{"issue":"3","key":"11267_CR24","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/0010-0285(73)90017-0","volume":"4","author":"EH Rosch","year":"1973","unstructured":"Rosch EH. Natural categories. Cogn Psychol. 1973;4(3):328\u201350. https:\/\/doi.org\/10.1016\/0010-0285(73)90017-0.","journal-title":"Cogn Psychol"},{"issue":"374","key":"11267_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1080\/01621459.1981.10477633","volume":"76","author":"JNK Rao","year":"1981","unstructured":"Rao JNK, Scott AJ. The analysis of categorical data from complex sample surveys: chi-squared tests for goodness of fit and Independence in two-way tables. J Am Stat Assoc. 1981;76(374):221\u201330. https:\/\/doi.org\/10.1080\/01621459.1981.10477633.","journal-title":"J Am Stat Assoc"},{"issue":"2","key":"11267_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.7326\/0003-4819-158-2-201301150-00574","volume":"158","author":"R Chou","year":"2013","unstructured":"Chou R, Cottrell EB. Screening for hepatitis C virus infection in adults : a systematic review for the USPSTF. Ann Intern Med. 2013;158(2):101\u20138. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK115423\/. https:\/\/doi.org\/10.7326\/0003-4819-158-2-201301150-00574.","journal-title":"Ann Intern Med"},{"issue":"4","key":"11267_CR27","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3138\/canlivj.2018-0011","volume":"1","author":"M Krajden","year":"2018","unstructured":"Krajden M, Cook D, Janjua NZ. Contextualizing Canada\u2019s hepatitis C virus epidemic. Can Liver J. 2018;1(4):218\u201330. https:\/\/doi.org\/10.3138\/canlivj.2018-0011.","journal-title":"Can Liver J"},{"issue":"8","key":"11267_CR28","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.2337\/dc14-0316","volume":"37","author":"B Menart-Houtermans","year":"2014","unstructured":"Menart-Houtermans B, R\u00fctter R, Nowotny B, Rosenbauer J, Koliaki C, Kahl S, et al. Leukocyte profiles differ between type 1 and type 2 diabetes and are associated with metabolic phenotypes: results from the German diabetes study (GDS). Diabetes Care. 2014;37(8):2326\u201333. https:\/\/doi.org\/10.2337\/dc14-0316.","journal-title":"Diabetes Care"},{"issue":"3","key":"11267_CR29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s10654-019-00494-6","volume":"34","author":"TJ VanderWeele","year":"2019","unstructured":"VanderWeele TJ. Principles of confounder selection. Eur J Epidemiol. 2019;34(3):211\u20139. https:\/\/doi.org\/10.1007\/s10654-019-00494-6.","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"11267_CR30","doi-asserted-by":"publisher","first-page":"669","DOI":"10.2307\/2337329","volume":"82","author":"J Pearl","year":"1995","unstructured":"Pearl J. Causal Diagrams for Empirical Research. Biometrika. 1995;82(4):669. https:\/\/doi.org\/10.2307\/2337329.","journal-title":"Biometrika"},{"issue":"1","key":"11267_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jssam\/smu021","volume":"3","author":"T Lumley","year":"2015","unstructured":"Lumley T, Scott A. AIC and BIC for modeling with complex survey data. J Surv Stat Methodol. 2015;3(1):1\u201318. https:\/\/doi.org\/10.1093\/jssam\/smu021.","journal-title":"J Surv Stat Methodol"},{"key":"11267_CR32","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-7138-7","volume-title":"An introduction to statistical learning","author":"G James","year":"2013","unstructured":"James G, Witten D, Hastie T, Tibshirani R. An introduction to statistical learning. New York: Springer New York; 2013. https:\/\/doi.org\/10.1007\/978-1-4614-7138-7."},{"key":"11267_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/9781119013563","volume-title":"Statistical analysis with missing data","author":"RJA Little","year":"2002","unstructured":"Little RJA, Rubin DB. Statistical analysis with missing data. Hoboken: John Wiley & Sons, Inc.; 2002. https:\/\/doi.org\/10.1002\/9781119013563."},{"issue":"2","key":"11267_CR34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1515\/jci-2014-0039","volume":"3","author":"G Ridgeway","year":"2015","unstructured":"Ridgeway G, Kovalchik SA, Griffin BA, Kabeto MU. Propensity score analysis with survey weighted data. J causal inference. 2015;3(2):237\u201349. https:\/\/doi.org\/10.1515\/jci-2014-0039.","journal-title":"J causal inference"},{"issue":"5","key":"11267_CR35","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1093\/aje\/kws241","volume":"177","author":"S Rose","year":"2013","unstructured":"Rose S. Mortality risk score prediction in an elderly population using machine learning. Am J Epidemiol. 2013;177(5):443\u201352. https:\/\/doi.org\/10.1093\/aje\/kws241.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"11267_CR36","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1080\/00273171.2011.540480","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin PC. A tutorial and case study in propensity score analysis: an application to estimating the effect of in-hospital smoking cessation counseling on mortality. Multivariate Behav Res. 2011;46(1):119\u201351. https:\/\/doi.org\/10.1080\/00273171.2011.540480.","journal-title":"Multivariate Behav Res"},{"key":"11267_CR37","volume-title":"RStudio","author":"Rstudio Team","year":"2019","unstructured":"Rstudio Team. RStudio. 2019. https:\/\/www.rstudio.com\/products\/team\/."},{"issue":"4","key":"11267_CR38","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1093\/aje\/kws412","volume":"177","author":"D Westreich","year":"2013","unstructured":"Westreich D, Greenland S. The table 2 fallacy: presenting and interpreting confounder and modifier coefficients. Am J Epidemiol. 2013;177(4):292\u20138. https:\/\/doi.org\/10.1093\/aje\/kws412.","journal-title":"Am J Epidemiol"},{"issue":"4","key":"11267_CR39","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/15321819.2018.1460272","volume":"39","author":"MH Orum","year":"2018","unstructured":"Orum MH, Kara MZ, Egilmez OB, Kalenderoglu A. Complete blood count alterations due to the opioid use: what about the lymphocyte-related ratios, especially in monocyte to lymphocyte ratio and platelet to lymphocyte ratio? J Immunoass Immunochem. 2018;39(4):365\u201376. https:\/\/doi.org\/10.1080\/15321819.2018.1460272.","journal-title":"J Immunoass Immunochem"},{"issue":"25","key":"11267_CR40","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/0024-3205(94)90136-8","volume":"54","author":"P Di Francesco","year":"1994","unstructured":"Di Francesco P, Falchetti R, Gaziano R, Lanzilli G, Belogi L, Ravagnan G, et al. Differential effects of short-term or prolonged cocaine exposure on peripheral blood cells in mice. Life Sci. 1994;54(25):2015\u201320. https:\/\/doi.org\/10.1016\/0024-3205(94)90136-8.","journal-title":"Life Sci"},{"issue":"6","key":"11267_CR41","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1086\/423384","volume":"39","author":"C-S Wang","year":"2004","unstructured":"Wang C-S, Yao W-J, Wang S-T, Chang T-T, Chou P. Strong Association of Hepatitis C Virus (HCV) infection and thrombocytopenia: implications from a survey of a community with Hyperendemic HCV infection. Clin Infect Dis. 2004;39(6):790\u20136. https:\/\/doi.org\/10.1086\/423384.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"11267_CR42","doi-asserted-by":"publisher","first-page":"e2017019","DOI":"10.4084\/MJHID.2017.019","volume":"9","author":"S Dahal","year":"2017","unstructured":"Dahal S, Upadhyay S, Banjade R, Dhakal P, Khanal N, Bhatt VR. Thrombocytopenia in patients with chronic hepatitis C virus infection. Mediterr J Hematol Infect Dis. 2017;9(1):e2017019. https:\/\/doi.org\/10.4084\/MJHID.2017.019.","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"11","key":"11267_CR43","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.3748\/wjg.v20.i11.2777","volume":"20","author":"D Revie","year":"2014","unstructured":"Revie D, Salahuddin SZ. Role of macrophages and monocytes in hepatitis C virus infections. World J Gastroenterol. 2014;20(11):2777\u201384. https:\/\/doi.org\/10.3748\/wjg.v20.i11.2777.","journal-title":"World J Gastroenterol"},{"issue":"S1","key":"11267_CR44","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.2105\/AJPH.2004.059204","volume":"95","author":"KJ Rothman","year":"2005","unstructured":"Rothman KJ, Greenland S. Causation and causal inference in epidemiology. Am J Public Health. 2005;95(S1):S144\u201350. https:\/\/doi.org\/10.2105\/AJPH.2004.059204.","journal-title":"Am J Public Health"},{"issue":"9","key":"11267_CR45","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","volume":"10","author":"B Hajarizadeh","year":"2013","unstructured":"Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol. 2013;10(9):553\u201362. https:\/\/doi.org\/10.1038\/nrgastro.2013.107.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"11267_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12954-018-0274-2","volume":"16","author":"AP Deryabina","year":"2019","unstructured":"Deryabina AP, Patnaik P, El-Sadr WM. Underreported injection drug use and its potential contribution to reported increase in sexual transmission of HIV in Kazakhstan and Kyrgyzstan. Harm Reduct J. 2019;16(1):1. https:\/\/doi.org\/10.1186\/s12954-018-0274-2.","journal-title":"Harm Reduct J"},{"issue":"5","key":"11267_CR47","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1002\/bimj.201600094","volume":"59","author":"Y Abdia","year":"2017","unstructured":"Abdia Y, Kulasekera KB, Datta S, Boakye M, Kong M. Propensity scores based methods for estimating average treatment effect and average treatment effect among treated: a comparative study. Biom J. 2017;59(5):967\u201385. https:\/\/doi.org\/10.1002\/bimj.201600094.","journal-title":"Biom J"},{"issue":"12","key":"11267_CR48","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/pds.3876","volume":"24","author":"AJ Spieker","year":"2015","unstructured":"Spieker AJ, Delaney JAC, McClelland RL. Evaluating the treatment effects model for estimation of cross-sectional associations between risk factors and cardiovascular biomarkers influenced by medication use. Pharmacoepidemiol Drug Saf. 2015;24(12):1286\u201396. https:\/\/doi.org\/10.1002\/pds.3876.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"11267_CR49","doi-asserted-by":"publisher","first-page":"f6409","DOI":"10.1136\/bmj.f6409","volume":"347","author":"N Freemantle","year":"2013","unstructured":"Freemantle N, Marston L, Walters K, Wood J, Reynolds MR, Petersen I. Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research. BMJ. 2013;347:f6409. https:\/\/doi.org\/10.1136\/bmj.f6409.","journal-title":"BMJ"},{"key":"11267_CR50","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.eclinm.2018.10.006","volume":"4\u20135","author":"G McKee","year":"2018","unstructured":"McKee G, Butt ZA, Wong S, Salway T, Gilbert M, Wong J, et al. Syndemic characterization of HCV, HBV, and HIV co-infections in a large population based cohort study. EClinicalMedicine. 2018;4\u20135:99\u2013108. https:\/\/doi.org\/10.1016\/j.eclinm.2018.10.006.","journal-title":"EClinicalMedicine."},{"issue":"1","key":"11267_CR51","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4103\/0974-777X.77299","volume":"3","author":"A Clem","year":"2011","unstructured":"Clem A. Fundamentals of vaccine immunology. J Glob Infect Dis. 2011;3(1):73\u20138. https:\/\/doi.org\/10.4103\/0974-777X.77299.","journal-title":"J Glob Infect Dis"},{"issue":"8","key":"11267_CR52","doi-asserted-by":"publisher","first-page":"e008033","DOI":"10.1136\/bmjopen-2015-008033","volume":"5","author":"J Zhang","year":"2015","unstructured":"Zhang J, Feng G, Zhao Y, Zhang J, Feng L, Yang J. Association between lymphocyte-to-monocyte ratio (LMR) and the mortality of HBV-related liver cirrhosis: a retrospective cohort study. BMJ Open. 2015;5(8):e008033. https:\/\/doi.org\/10.1136\/bmjopen-2015-008033.","journal-title":"BMJ Open"},{"issue":"2","key":"11267_CR53","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s00535-004-1519-2","volume":"40","author":"M Ikeda","year":"2005","unstructured":"Ikeda M, Fujiyama S, Tanaka M, Sata M, Ide T, Yatsuhashi H, et al. Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon. J Gastroenterol. 2005;40(2):148\u201356. https:\/\/doi.org\/10.1007\/s00535-004-1519-2.","journal-title":"J Gastroenterol"},{"issue":"1","key":"11267_CR54","doi-asserted-by":"publisher","first-page":"e54289","DOI":"10.1371\/journal.pone.0054289","volume":"8","author":"G Biino","year":"2013","unstructured":"Biino G, Santimone I, Minelli C, Sorice R, Frongia B, Traglia M, et al. Age- and sex-related variations in platelet count in Italy: a proposal of reference ranges based on 40987 subjects\u2019 data. PLoS One. 2013;8(1):e54289. https:\/\/doi.org\/10.1371\/journal.pone.0054289.","journal-title":"PLoS One"},{"key":"11267_CR55","volume-title":"Haematology Normal Adult Reference Ranges. RWT Pathology Services","author":"National Health Service","year":"2019","unstructured":"National Health Service. Haematology Normal Adult Reference Ranges. RWT Pathology Services. 2019. https:\/\/www.royalwolverhampton.nhs.uk\/services\/service-directory-a-z\/pathology-services\/departments\/haematology\/haematology-normal-adult-reference-ranges\/."}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11267-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-021-11267-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11267-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T12:06:36Z","timestamp":1626177996000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-021-11267-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,13]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["11267"],"URL":"https:\/\/doi.org\/10.1186\/s12889-021-11267-w","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,13]]},"assertion":[{"value":"25 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The University of British Columbia\u2019s Policy 89, item 7.10.3 on studies involving human participants and Article 2.2 of the Tri-Council Policy Statement on Ethical Conduct for Research Involving Humans, provide ethical support of the study. As described in both policies research ethics board approval is not required for studies involving publicly available data such as that of NHANES. NHANES is a publicly available dataset administered by the National Center for Health Statistics, written informed consent was provided by all participants to the study investigators. The authors adhered to ethical principles, described in the declaration of Helsinki, and followed ethical guidelines or regulations provided by the University of British Columbia.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable, as all presented data is de-identified.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1388"}}